Healthcare -
Biotechnology - NASDAQ - US
$ 0.371
-11.7 %
$ 1.8 M
Market Cap
-0.01
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
99.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Panbela Therapeutics, Inc.
PBLA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PBLA
EBIT FORECAST
EBIT Forecast Chart PBLA
NET INCOME FORECAST
Net Income Chart PBLA